Search Results - Luo, Cailu

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    CDK4/6 inhibitors plus endocrine therapy vs. placebo plus endocrine therapy for HR+/HER2- advanced breast cancer: a phase III RCTs based meta-analysis

    CDK4/6 inhibitors plus endocrine therapy vs. placebo plus endocrine therapy for HR+/HER2- advanced breast cancer: a phase III RCTs based meta-analysis by Luo, Cailu, Yu, Kunlin, Luo, Xiaodan, Lian, Tao, Liu, Xuejuan, Xu, Wang, Jin, Zhongkui

    Published in BMC cancer
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The novel circFKBP8/miR-432-5p/E2F7 cascade functions as a regulatory network in breast cancer

    The novel circFKBP8/miR-432-5p/E2F7 cascade functions as a regulatory network in breast cancer by Jin, Zhongkui, Xu, Wang, Yu, Kunlin, Luo, Cailu, Luo, Xiaodan, Lian, Tao, Liu, Changshan

    Published in Hereditas
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    A rare case of concomitant endometrioid adenocarcinoma arising from uterine adenomyosis and clear cell carcinoma arising from parametrial deep endometriosis

    A rare case of concomitant endometrioid adenocarcinoma arising from uterine adenomyosis and clear cell carcinoma arising from parametrial deep endometriosis by Zhou, Cailu, Luo, Xiaojing, Tang, Mengjie, Luo, Fangyuan, Liao, Zhi

    Published in BMC women's health
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Major Traditional Probiotics: Comparative Genomic Analyses and Roles in Gut Microbiome of Eight Cohorts

    Major Traditional Probiotics: Comparative Genomic Analyses and Roles in Gut Microbiome of Eight Cohorts by Luo, Guangwen, Li, Bailiang, Yang, Cailu, Wang, Yutang, Bian, Xin, Li, Wan, Liu, Fei, Huo, Guicheng

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    CAR T-cell therapy combined with autologous hematopoietic cell transplantation in patients with refractory/relapsed Burkitt Lymphoma

    CAR T-cell therapy combined with autologous hematopoietic cell transplantation in patients with refractory/relapsed Burkitt Lymphoma by Liu, Yifan, Xiao, Gangfeng, Liu, Yang, Tu, Sanfang, Xue, Bin, Zhong, Yadi, Zhang, Cailu, Zhou, Lili, Ye, Shiguang, Lu, Yan, Xiu, Bing, Zhang, Wenjun, Ding, Yi, Fu, Jianfei, Li, Ping, Huang, Liang, Luo, Xiu, Liang, Aibin

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  6. 6
    mFOLFOXIRI with or without bevacizumab for conversion therapy of RAS/BRAF/PIK3CA mutant unresectable colorectal liver metastases: the FORBES non-randomized phase II trial

    mFOLFOXIRI with or without bevacizumab for conversion therapy of RAS/BRAF/PIK3CA mutant unresectable colorectal liver metastases: the FORBES non-randomized phase II trial by Shen, Cailu, Hu, Huabin, Cai, Yue, Ling, Jiayu, Zhang, Jianwei, Wu, Zehua, Xie, Xiaoyu, Huang, Meijin, Wang, Hui, Kang, Liang, Lan, Ping, Wu, Xiaojian, Liu, Guangjian, Wan, Yunle, Zhou, Zhiyang, Huang, Yan, Li, Fangqian, Wang, Huaiming, Ma, Tenghui, Luo, Shuangling, Cai, Yonghua, Shi, Lishuo, Deng, Yanhong

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: